Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roman A. Gapeshin"'
Autor:
Roman A. Gapeshin, Evgeny R. Barantsevich, Dmitry I. Rudenko, Oksana V. Posokhina, Tima R. Stuchevskaya
Publikováno v:
Учёные записки Санкт-Петербургского государственного медицинского университета им. Акад. И.П. Павлова, Vol 26, Iss 1, Pp 9-19 (2019)
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous immune-mediated peripheral neuropathy with progressive or relapse-remitting course. Incidence of CIDP ranged between 1 and 8.9/100 000. Recently, most frequent therapies for
Externí odkaz:
https://doaj.org/article/43560cda30f24029ab4feb800128b50c
Publikováno v:
Вопросы современной педиатрии, Vol 15, Iss 4, Pp 344-351 (2016)
Despite the fact that orphan (rare) diseases are characterized by a very low prevalence rate, a considerable number of people worldwide suffer from these diseases. The United States and the European Union developed a variety of economic and administr
Externí odkaz:
https://doaj.org/article/e6797533f54b43649e697a6af757af0d
Autor:
Andrey G. Smochilin, Maria V. Yakovleva, Elena S. Tarabanova, Artem S. Lelyokin, Alexey A. Yakovlev, Roman A. Gapeshin
Publikováno v:
Vestnik of Saint Petersburg University. Medicine. 13:174-184
The paper presents the experience of using the technology of computer stabilometry with biologic feedback in the rehabilitation of patients with paraproteinemic polyneuropathy. In the process of observation of 16 patients with clinical manifestations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dec580a73a5ce1635b38444b8b158736
https://doi.org/10.21638/11701/spbu11.2018.205
https://doi.org/10.21638/11701/spbu11.2018.205
Autor:
Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev, Aleksei Sergeevich Kolbin, Andrey Vladislavovich Pavlysh
Publikováno v:
Фармакоэкономика, Vol 8, Iss 2, Pp 3-10 (2015)
Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb3a7ec0ad0de2c48ac43cc75993b75
https://www.pharmacoeconomics.ru/jour/article/view/98
https://www.pharmacoeconomics.ru/jour/article/view/98
Autor:
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
Publikováno v:
Фармакоэкономика, Vol 8, Iss 2, Pp 3-10 (2015)
Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal definition of a rare disease and no universal approach to orphan drugs legislation. As a result, decision-making in this field requires results of pharmacoec
Externí odkaz:
https://doaj.org/article/0e6d3309dce7495b86dcf8a886b63afb